Mucoepidermoid carcinoma (MEC) is a rare cancer typically affects salivary glands. The development of MEC in the context of the thyroglossal duct is a rare finding. We describe the clinical manifestation, histopathological results, and treatment strategy of a 72-year-old woman who was diagnosed with intermediate-grade MEC originating from ectopic salivary gland tissue within a thyroglossal duct remnant.

Mucoepidermoid Carcinoma in Ectopic Salivary Tissue of the Thyroglossal Duct: A Case Report / Gioffre’, V., Galli, A., Callea, M., Cianci, V., Pini, G., Karligkiotis, A., Salerno, E., Lira Luce, F., Giordano, L.. - In: INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD AND NECK SURGERY. - ISSN 2231-3796. - 78:4(2026), pp. 2362-2366. [10.1007/s12070-026-06376-0]

Mucoepidermoid Carcinoma in Ectopic Salivary Tissue of the Thyroglossal Duct: A Case Report

Galli A.
Secondo
;
Karligkiotis A.;Giordano L.
Ultimo
Supervision
2026-01-01

Abstract

Mucoepidermoid carcinoma (MEC) is a rare cancer typically affects salivary glands. The development of MEC in the context of the thyroglossal duct is a rare finding. We describe the clinical manifestation, histopathological results, and treatment strategy of a 72-year-old woman who was diagnosed with intermediate-grade MEC originating from ectopic salivary gland tissue within a thyroglossal duct remnant.
2026
CRTC1-MAML2 fusion; Ectopic salivary gland; Intermediate-grade tumor; Mucoepidermoid carcinoma; Sistrunk technique; Thyroglossal duct remnant
File in questo prodotto:
File Dimensione Formato  
Mucoepidermoid Carcinoma in Ectopic 2026.pdf

solo gestori archivio

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Tutti i diritti riservati
Dimensione 733.71 kB
Formato Adobe PDF
733.71 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/203636
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact